|
|
 |
|
Viewing report
|
|
|
|
Lifecycle Management Strategies - Key Tools to Maximize Return on Investment in a Tough Healthcare Environment
CBR Pharma Insights, Sep 2009
Pharmaceutical companies continuing to face the challenges of declining R&D productivity and rising costs, while trying to negotiate an increasingly risk averse and cost constrained healthcare marketplace, need to focus on improving their lifecycle management strategies in order to maximize their portfolios sales over the long term.
In an increasingly difficult operating environment, optimizing LCM strategies is an important way for companies to maximize their return on investment.
However, the changing environment is also impacting the effectiveness of the LCM strategies themselves. This means that LCM selection and implementation needs to be a dynamic and adaptive process and up to date market intelligence is key. Effective LCM planning begins early in the lifecycle of a drug, ideally during the R&D process and should include cross-portfolio considerations.
Reasons to Purchase
- Learn why lifecycle management is important in the pharmaceutical industry and when it should be employed for your products
- Understand what factors will have an impact on the lifecycle management strategy you choose and how they may differ depending upon the type of product you have and whether you are looking at the US or ex-US
- Gain insights into the various types of lifecycle management strategies that are being used today through actual case studies examples and our analysis of them
- Learn when to implement your lifecycle management strategy and who should be driving it forward
- Identify which products have done well with the lifecycle management strategies they’ve employed and why
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pharmaceutical Lifecycle Management: Strategy Selection and Execution
Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity
The Impact of US Healthcare Reform on Pharma
Injectable Drug Delivery: Market Impact and Industry Trends
Pharmaceutical Strategic Alliances: Maximizing Returns from Collaborative Development and Commercialization
Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
Pulmonary Inhalers & Systemic Drug Delivery: Devices, Drugs, Therapeutics, Market Factors & Forecasts
Evidence-Based Medicine: Current Use and Future Impact on Global Clinical and Reimbursement Practice
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
Personalized Medicine 2010
|
|
|
|
